The future of medicine depends, in
large part, on the ability to pinpoint, study and treat disease with
increasing precision. At Coretech Holdings, we are creating tools
that make that possible. One of the large focuses of Coretech Holdings
today is the diagnosis of cancer through the use of innovative and patented
histotechnology tools. A new series of products are being developed
to meet the needs of cancer diagnosis in the "molecular age" in histopathology.
TOOLS FOR BETTER MEDICINE
Business
Overview
Business
Model
Core
Values
Products
& Services
History
History
--
Since our inception in 1998, we have grown from two employees with
a single product, to a company now markets and sells more than 900
highly specialized products, with annual growth rates exceeding 50
percent.
Milestones in our history include:
November 1998
Coretech Holdings, Inc. is founded by Doug Martin and Jim Unnerstall
May 1999
Coretech purchases The Vibratome Company, a manufacturer of tissue
sectioning equipment used in laboratory research. Martin and Unnerstall's
vision: to update and broaden the company's respected, but 20-year-old
product line to accommodate an expanding, more sophisticated range
of laboratory research needs. The company begins expanding The Vibratome
product line with hundreds of new scientific instruments to market
to a fragmented audience of M.D.- and Ph.D.-level university researchers.
November 2000
Vibratome's "classic" vibratory microtome is re-engineered
and relaunched, the line expanded into a family of five models with
a wide range of accessories and ancillary equipment.
January 2001
Coretech acquires a microforge business from Alcatel in France and
founds the GlasswoRx Company, which manufactures precision tools
used in the production of glass microinstruments.
April 2001
Coretech launches myNeuroLab.com, a vertically focused website that
makes it easy for researchers to find everything they need to build
and cost out a neurology lab from scratch - including Coretech's
own branded products.
May 2001
Coretech introduces a new line of BENCHmarkTM steriotaxic instruments.
October 2001
Coretech introduces a patent pending line of Digital Stereotaxic
Instruments.
December 2001
The company's Vibratome division introduces the UltraPro 5000 open-top
cryostat for use in cutting frozen tissue in hospitals, universities
and research markets.
April 2002
Coretech forms strategic alliance with Histotech of Europe to set
up and support all of Coretech's businesses in Europe. The agreement
includes complete management of dealer networks, repair services
and marketing. The alliance creates a firm foundation for dramatically
growing Coretech's European operations.
July 2002
Coretech moves into new corporate headquarters and manufacturing
center in Berkeley, Missouri.
August 2002
Coretech signs an exclusive distribution agreement with Medite,
a German manufacturer of tissue staining and embedding instruments.
The agreement allows the company to compete aggressively in the
histology market. Coretech also expands sales into Korea and India
through two new distributors-Care BioMedicals, Inc., India and Essence
Medical, Inc., Korea.
September 2002
Coretech is named one of the Technology Top 50, a ranking of the
50 leading technology companies in the St. Louis region
October 2002
Coretech introduces new manipulator technologies for stereotaxic
instruments with its Deluxe Digital line of products. The new technology
helps position the company as the premier supplier of stereotaxic
instrumentation.
December 2002
INC magazine names Coretech's web initiative one of 2002's "Killer
Applications" of the internet.
October 2004
Coretech launches the next generation Stereotaxic systems that incorporate
microprocessor and advanced math algorithms to dramatically change the way
Stereotaxic surgeries are done.
January 2005
Coretech announces the arrival of Dr. James McCormick to the company's board
of directors. Dr. McCormick takes an active role as a Scientific Advisor on
histotechnology tools and innovations.
July 2005
Coretech announce a joint venture called McCormick Scientific with Dr. James
McCormick and Bush O'Donnel Equity partners. The new entity purchased the
Paraplast product line from Tyco Healthcare.
September 2005
Coretech launches McCormick Scientific to the histology community at the
National Society of Histotechnology in Fort Lauderdale.
|